Navigation Links
Inovio Pharmaceuticals Reports 2010 Fourth Quarter and Year End Financial Results

olders' equity:Preferred stock—par value $0.001; Authorized shares: 10,000,000, issued and
outstanding: 26 and 26 at December 31, 2010 and December 31, 2009, respectively

—Common stock—par value $0.001; Authorized shares: 300,000,000, issued and
outstanding: 105,038,192  at December 31, 2010 and 102,746,058 at December 31, 2009


102,746Additional paid-in capital241,233,334

237,577,970Accumulated deficit(194,838,229)

(177,224,433)Accumulated other comprehensive income2,850

105,796Total Inovio Pharmaceuticals, Inc. stockholders' equity46,502,993

60,562,079Non-controlling interest597,918

622,868Total stockholders' equity47,100,911

61,184,947Total liabilities and stockholders' equity$56,067,391

$80,628,917Inovio Pharmaceuticals, Inc.CONSOLIDATED STATEMENTS OF OPERATIONSFor the Years ended December 31,201020092008Revenues:License fee and milestone revenue$213,916


$791,401License fee and milestone revenue from affiliated entity313,306


—Revenue under collaborative research and development arrangements—


1,077,967Grants and miscellaneous revenue5,549,583


228,264Miscellaneous revenue from affiliated entity67,900


—Total revenues6,144,705


2,097,632Operating expenses:Research and development13,256,606


5,750,494General and administrative12,108,261


10,005,602Total operating expenses25,364,867


15,756,096Loss from operations(19,220,162)


(13,658,464)Other income (expense):Other income/(expense), net2,476,816


49,006Interest income, net74,514


643,836Loss from investment in affiliated entity(969,914)


—Net loss(17,638,746)


SOURCE Inovio Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. Inovio Pharmaceuticals Licenses Non-DNA Vaccine Tumor Therapy Technology to OncoSec Medical
2. OncoSec Medical Licenses Non-DNA Vaccine Tumor Therapy Technology from Inovio Pharmaceuticals
3. Inovio Pharmaceuticals Partner ChronTech Initiates Phase II Clinical Trial of Hepatitis C Virus DNA Vaccine Using Inovios Electroporation Delivery Technology
4. Inovio Pharmaceuticals to Present at ROTH 23rd Annual Growth Stock Conference
5. Inovio Pharmaceuticals to Present at Cowen & Co. Health Care Conference
6. Inovio Pharmaceuticals to Present at Partnering and Scientific Conferences
7. Inovio Pharmaceuticals Unveils Needle-free, Contactless Electroporation Technology for DNA Vaccine Delivery
8. Inovio Pharmaceuticals Dual-Antigen SynCon™ DNA Vaccine for Prostate Cancer Induces Robust Responses in Preclinical Trial
9. University of Southampton and Inovio Pharmaceuticals Initiate Phase 2 Clinical Study to Evaluate Leukemia DNA Vaccine Using Electroporation Delivery Technology
10. Inovio Pharmaceuticals Closes $24.3 Million Registered Offering
11. Akrimax Pharmaceuticals, LLC, Introduces NitroMist® (Nitroglycerin Lingual Aerosol) 400mcg/Spray
Post Your Comments:
(Date:10/8/2015)... DUBLIN , Oct. 08 2015 /PRNewswire/ ... announced the addition of the "Natural ... Life Sciences Industry by Type (Rule-Based, Statistical, ... Europe, Asia-Pacific, Middle East and Africa, Latin ... report to their offering. --> ...
(Date:10/8/2015)... ATLANTA , Oct. 8, 2015  Celtaxsys, a ... for patients suffering from orphan inflammatory diseases, announced today ... phase 2 clinical trial for its flagship compound, acebilustat, ... be conducted at approximately 60 sites in ... the EU sites anticipated to begin enrollment early 2016. ...
(Date:10/8/2015)... , Oct. 8, 2015 Hill-Rom Holdings, ... 2015 fourth quarter earnings conference call and webcast from ... of Thursday, November 5, 2015. . ... Release:  The earnings release will be issued that morning ... Hill-Rom website at . ...
Breaking Medicine Technology:
... DIEGO and SUNNYVALE, Calif., April 16 ,Pharmacyclics, Inc. ... the anti-tumor activity of PCI-27483, the company,s,small-molecule Factor ... Meeting of the American Association for Cancer Research ... Researchers reported that in animal models of ...
... Intravenous to Subcutaneous Conversion -, SAN ... HALO ), a biopharmaceutical company developing ... new pre-clinical findings on the local tolerability ... the American,Association for Cancer Research (AACR) conference., ...
Cached Medicine Technology:
(Date:10/9/2015)... , ... October 09, 2015 , ... ... medical staffing franchise, was recognized by Cabarrus County Active Living and Parks for ... home care company’s dedication to consistently going above and beyond the ...
(Date:10/9/2015)... ... October 09, 2015 , ... ... of Kimberly Post, CPA , as Chief Financial Officer. Kimberly will ... compliance and assist with any strategic acquisitions. Kimberly’s experience guiding healthcare services ...
(Date:10/9/2015)... ... , ... ISI Telemanagement Solutions, Inc., a leading Unified Communications ... Partner Appreciation Event. The event will be held October 15, 2015, at the ... , This year’s partner event focuses on the themes of reinvention, innovation, and ...
(Date:10/8/2015)... ... October 09, 2015 , ... ... five year anniversary this November. The support post-concussion group was started by Steven ... Trainers’ Society (PATS) member. The group was started in November 2010 to ...
(Date:10/8/2015)... , ... October 08, 2015 , ... Florida Hospital, the ... in the team’s Treasure Chests 5K Run/Walk benefitting breast cancer research and patient services. ... held on Sunday morning, October 11th at Raymond James Stadium prior to the Bucs ...
Breaking Medicine News(10 mins):
... wore acupressure wristbands had much less nausea while receiving ... to anti-nausea medication, according to a study published in ... by University of Rochester Medical Center researchers. , ... essentially, an outcome related to your body that you ...
... Applications Show Individuals How Much They Will Pay ... and Improve Their HealthcareANN ARBOR, Mich., April 8 ... healthcare and its cost, employers and health insurers ... beneficiaries make well-informed decisions about their health and ...
... PHILADELPHIA, April 8 Kyle,s Treehouse -- an ... initiative for Autism Awareness Month: Autism151, 150 ... on the positive side of the autism experience by creating ... inspiration and success with one another, giving them even more ...
... Tax Would Raise Critical Funds for State Tobacco Prevention ... products - including spit and chew tobacco and flavored ... should be taxed at the same rate as cigarettes ... today by a coalition of public health organizations.(Logo: ...
... half of non-smoking New Yorkers have elevated levels of ... recently exposed to toxic second-hand smoke in concentrations high ... by-product of nicotine breakdown, is not harmful itself but ... study, published online this week in the journal ...
... Meeting of the European Society of Cardiology Council on ... with the Irish Nurses Cardiovascular Association (INCA), is being ... 24-25 April. , The meeting - considered by ... and allied health professionals - will show case the ...
Cached Medicine News:
... The DataMate Laser Sheeted ... consists of laser-printable sheets ... wristband and laser labels ... The wristbands clear, fold-over ...
Use these popular insert style bands to secure a bar code label inside the wristband pocket for maximum convenience and security....
As part of a complete all-in-one system, Sentry LabelBand securely seals inexpensive paper labels inside a clear, adhesive shield. LabelBand provides easy and accurate bar code scanning and protectio...
... Designed for use in ... Alzheimer units, where you may ... which is easy to apply ... The band's width is increased ...
Medicine Products: